Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

62.90
BATS BZX Real-Time Price
As of 12:43pm ET
 -0.29 / -0.46%
Today’s Change
46.01
Today|||52-Week Range
63.74
+7.63%
Year-to-Date
Infinity/ Bristol-Myers Adds TNBC Patients to Clinical Deal
11:18am / Zacks.com - Paid Partner Content
Oncology Space in Focus this Week on ESMO Presentations
Sep 15 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J Drug Gets CRL, Label Expansion for Merck and BMY Drugs
7:29am / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Collaborates With Halozyme for ENHANZE
Sep 15 / Zacks.com - Paid Partner Content
Abbvie/Bristol-Myers Inks Deal to Develop Therapeutic Cancer
Sep 25 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO
Sep 15 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Opdivo Gets Approval for Liver Cancer
Sep 25 / Zacks.com - Paid Partner Content
Nektar (NKTR) Starts PROPEL Combo Study for Cancer Candidate
Sep 13 / Zacks.com - Paid Partner Content
AstraZeneca climbs as Bernstein backs takeover talk
Sep 22 / FT.com - Paid Partner Content
Bristol-Myers Reports Positive Results from Melanoma Study
Sep 12 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Pfizer Files Suit against J&J, Supernus Hit by Study Update
Sep 22 / Zacks.com - Paid Partner Content
Company News For Sep 12, 2017
Sep 12 / Zacks.com - Paid Partner Content
2 Important Dates for Big Pharma
Sep 20 / GuruFocus News - Paid Partner Content
Hopes for cancer treatment buoy AstraZeneca
Sep 07 / FT.com - Paid Partner Content
Roche's (RHHBY) Tecentriq Studies Put on Partial Hold by FDA
Sep 18 / Zacks.com - Paid Partner Content
Pfizer to test drug for liver disease linked to rising obesity
Aug 29 / FT.com - Paid Partner Content